Hemophilia - 114 Studies Found Completed : Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects : Acquired Bleeding Disorder Acquired Haemophilia : 2012-03-21 : Drug: activated recombinant human factor VII One single dose administration, injected i.v. (into the vei Recruiting : Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A : Acquired Hemophilia A : 2015-10-29 : Biological: OBIZUR Treating physician will determine treatment regimen, frequency of laboratory and clin No longer available : Expanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodies : Acquired Hemophilia A : 2013-10-21 : Biological: OBI-1 Other Name: B-Domain Deleted Recombinant Porcine Factor VIII Terminated : Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A : Hemophilia A : 2006-03-23 : Drug: Rituxan Acquired Hemophi Completed : Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A : Hemophilia A : 2010-08-06 : Biological: OBI-1 Intravenous infusion Completed : Bleeding Symptoms of Carriers of Hemophilia A and B : Hemophilia : 2009-12-09 Completed : A Feasibility Study to Collect Data in Patients With Haemophilia : Hemophilia : 2008-11-12 : Other: Laboratory variables 1 visit Completed : Inhibitor Development in Patients With Hemophilia A Undergoing Surgery : Hemophilia A : 2012-04-04 Completed : Study of a pd vWF/FVIII, Biostate®, in Subjects With Haemophilia A : Hemophilia A : 2009-04-09 : Biological: Biostate® [SP] Completed : Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A : Hemophilia A : 2002-06-05 : Drug: ReFacto AF <<< Previous | Next >>>